ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia.
10.3324/haematol.2019.230482
Saved in:
Main Authors: | Zhou, Jianbiao, Yiying Quah, Jessie, Ng, Yvonne, Chooi, Jing-Yuan, Hui-Min Toh, Sabrina, Lin, Baohong, Zea Tan, Tuan, Hosoi, Hiroki, Osato, Motomi, Seet, Qihui, Ooi, Lisa AG, Lindmark, Bertil, McHale, Mark, Chng, Wee-Joo |
---|---|
Other Authors: | DEAN'S OFFICE (MEDICINE) |
Format: | Article |
Published: |
Ferrata Storti Foundation
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/229089 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
A Specific ChREBP and PPARα Cross-Talk Is Required for the Glucose-Mediated FGF21 Response
by: Iroz, Alison, et al.
Published: (2017) -
DCAS9 CHIP-MS REVEALS THE LOCAL CHROMATIN COMPOSITION BY LABEL-FREE QUANTITATIVE PROTEOMICS
by: YONG WAI KHANG
Published: (2022) -
Langlois Ch., Seignobos Ch. Và vấn đề phương pháp nghiên cứu lịch sử
by: Đoàn, Thị Hòa
Published: (2020) -
Minimum and Maximum Available Prices and the outcome of Competition: A Meta-Analysis of Oligopoly Experiments
by: WANG YUE
Published: (2011) -
Chromatin interaction analysis with Paired-End Tag Sequencing (ChIA-PET) for mapping chromatin Interactions and Understanding Transcription Regulation
by: Goh, Y., et al.
Published: (2014)